RLS
LIVE

Serial Number

79417341

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Jan 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RLS Trademark

Serial Number: 79417341

RLS is a trademark filed by Telix Pharmaceuticals Limited on January 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

January 23, 2025

Registration Date

Not Registered

Published for Opposition

January 13, 2026

Goods & Services

Isotopes for medical purposes; Radio-isotope markers for therapeutic or diagnostic use; Chemical products for pharmaceutical use being pharmaceutical products for the diagnosis and treatment of cancer; Pharmaceutical drugs being pharmaceutical products for the diagnosis and treatment of cancer, or skeletal, renal, cardiovascular or neurological disorders; Pharmaceutical preparations for diagnosing and suppressing tumors; Pharmaceutical preparations for the treatment of cancer; Diagnostic radiopharmaceutical preparations

Transportation of goods; transport and storage of chemicals; storage of pharmaceuticals.

Custom manufacture of pharmaceuticals; custom manufacture of pharmaceutical preparations.

Calibration of medical apparatus for detecting and treating cancer or skeletal, renal, cardiovascular or neurological disorders; Calibration of laboratory test equipment; Radiation measurement services; Scientific research and development for medical purposes in the fields of cancerous diseases or skeletal, renal, cardiovascular or neurological disorders

Diagnostic imaging apparatus for medical use; Medical apparatus for detecting cancer, or skeletal, renal, cardiovascular or neurological disorders; Systems comprising medical apparatus and accessories for administering measured doses of pharmaceutical preparations, namely, infusion and injection devices for administering drugs; Applicators for pharmaceutical preparations, namely, medical syringes and infusion sets

Wholesale and retail store services featuring radiopharmaceuticals for clinical and medical use; Wholesale and retail store services featuring pharmaceuticals, medical preparations and veterinary preparations; Wholesale and retail store services featuring medical apparatus for detecting cancer, or skeletal, renal, cardiovascular or neurological disorders

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2025 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Sep 11, 2025 LIMG
REFUSAL PROCESSED BY IB
Jun 28, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 6, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 2, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 1, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 23, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR